Short answer · Medically reviewed summary · Last updated: 2026-04-07
Pigmented villonodular synovitis (PVNS) is most commonly referred to today as tenosynovial giant cell tumor (TGCT). While historical medical literature frequently uses the term PVNS, modern clinical guidelines prefer the classification of TGCT to better reflect the tumor-like nature and underlying genetic drivers of the condition. What are the common synonyms and historical names for this condition? Because Pigmented villonodular synovitis was historically described before its molecular mechanisms were fully understood, it has accumulated several names over the decades.
Pigmented villonodular synovitis (PVNS) is most commonly referred to today as tenosynovial giant cell tumor (TGCT). While historical medical literature frequently uses the term PVNS, modern clinical guidelines prefer the classification of TGCT to better reflect the tumor-like nature and underlying genetic drivers of the condition.
Because Pigmented villonodular synovitis was historically described before its molecular mechanisms were fully understood, it has accumulated several names over the decades. In older clinical records, you may encounter terms such as xanthomatous giant cell tumor, benign synovioma, or villonodular synovitis. These terms describe the physical appearance of the joint lining during surgery or imaging but do not capture the biological nature of the disease. In the context of the 31 members of our DiseaseMaps community living with this condition, you may find that patients use these terms interchangeably, though the medical community is moving toward standardized terminology.
The variety of names for Pigmented villonodular synovitis stems from the evolution of pathology and the discovery of the CSF1 (colony-stimulating factor 1) gene translocation. Historically, doctors named the condition based on what they saw under a microscope or during an arthroscopy—such as "pigmented" (due to iron deposits) or "villonodular" (due to the frond-like, nodular growth). As research progressed, it became clear that this condition is a localized or diffuse neoplasm. Consequently, the World Health Organization (WHO) now classifies it under the umbrella of tenosynovial giant cell tumors, a change designed to help researchers better categorize clinical trials and treatment protocols.
In modern medical systems, the terminology is shifting to improve diagnostic clarity. Below is how Pigmented villonodular synovitis is categorized in major medical databases:
While Pigmented villonodular synovitis remains a widely recognized and accepted term in clinical practice, using the term "tenosynovial giant cell tumor (TGCT)" can be helpful when searching for the most recent clinical literature or specialized oncology centers. Many specialists now prefer TGCT because it aligns with modern molecular diagnostics. If you are reviewing your medical records or discussing treatment plans, it is perfectly appropriate to ask your physician: "Is my diagnosis classified as localized or diffuse tenosynovial giant cell tumor?" This distinction is critical, as it often dictates the surgical approach and the potential use of targeted systemic therapies, such as CSF1R inhibitors.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.